For US home diagnostic kits, I’d compare the three models less on “marketing capability” and more on who owns the intersection of growth, claims substantiation, regulatory interpretation, and execution.
FDA treats IVD test kits as medical devices, and the regulatory requirements depend on the individual product and risk classification. For direct-to-consumer tests, FDA considers analytical validity, clinical validity, claims, and whether consumer-facing instructions/results are understandable. The FTC separately expects health-product advertising claims to be truthful, not misleading, and backed by appropriate scientific evidence—including implied claims created by the overall “net impression” of an ad.
A useful comparison framework
| Dimension | Specialist compliance partner | Broad agency | In-house team |
|---|
| Regulatory/claims expertise | Usually strongest | Highly variable | Must be built/hired |
| Creative & performance marketing | Variable | Usually strongest | Can become strong over time |
| Speed to launch | Medium | Fast | Slow initially |
| Institutional knowledge | Medium | Lower unless deeply embedded | Strongest |
| Fixed cost | Medium | Medium–high | High |
| Variable/scaling cost | Medium | Medium–high | Medium |
| Control | Medium | Lower | Highest |
| Ability to challenge risky claims | Strong if truly independent | Depends on account team | Depends on internal incentives |
| Channel breadth | Usually narrower | Strong | Depends on hiring |
| Long-term capability creation | Low–medium | Low | Highest |
The five things I'd actually score
Instead of giving each option a generic 1–5 rating, define your own weights around these:
1. Claims/compliance risk management — probably the most important
Ask each option:
- Who reviews every product claim before publication?
- Do they understand the distinction between FDA labeling and FTC advertising?
- Can they evaluate implied claims, not just explicit wording?
- Who maintains a claim-substantiation library?
- What happens when a growth marketer wants to test a more aggressive claim?
- Can they trace every material claim back to its supporting evidence?
This matters because FTC responsibility extends beyond literal statements to the overall consumer takeaway, and health claims generally require appropriate scientific substantiation.
2. Growth capability
Measure demonstrated capability in:
- Paid search/social
- SEO/content
- CRO and landing pages
- Lifecycle/email/SMS
- Creative testing
- Affiliate/influencer marketing
- Marketplace/e-commerce optimization
- CAC, conversion rate and LTV improvement
A compliance specialist may protect you exceptionally well but not know how to build a high-performing acquisition engine. Conversely, a conventional growth agency may be excellent at performance marketing but insufficiently equipped for diagnostic-product claims.
3. Speed vs. organizational learning
Ask: Where will the expertise live after 24 months?
With an agency, you potentially get immediate expertise but remain dependent on the vendor. With an internal team, you incur hiring and management costs but accumulate institutional knowledge.
A particularly useful metric is:
How much of our marketing capability becomes an asset we own rather than an external service we rent?
4. Economics at your current scale
Don't compare retainers alone. Build a 24-month total-cost model including:
- Retainer/agency fees
- Internal salaries
- Compliance/legal review
- Creative production
- Media-management fees
- Software/tools
- Recruiting
- Training
- Management overhead
- Cost of delayed launches
- Expected cost of compliance failures or forced creative/product changes
Then compare the cost against incremental contribution margin, rather than revenue alone.
5. Accountability
Make each option commit to the same KPIs. For example:
- Revenue
- Contribution margin
- CAC
- New-customer conversion
- Repeat purchase/LTV
- Landing-page conversion
- Qualified traffic
- Creative testing velocity
- Percentage of campaigns passing compliance review without rework
That makes the choice much more concrete than comparing agency presentations.
One model worth considering: hybrid
You don't necessarily have to choose one of the three completely.
For a diagnostic-kit company, a potentially useful structure is:
Internal: brand strategy, customer knowledge, analytics, product positioning, final decision-making.
Compliance specialist: claims framework, substantiation review, regulatory monitoring, review of high-risk campaigns.
Agency/freelancers: paid media, creative production, SEO, CRO and channel execution.
Over time, you could bring the highest-value recurring capabilities in-house while retaining specialist compliance expertise.
I'd be particularly cautious about making the broad agency the sole gatekeeper for claims compliance. The FTC explicitly says health-product advertisers need substantiation before disseminating claims, and FDA's treatment of DTC tests makes the product's intended use and claims important regulatory considerations.
A practical decision rule
Rather than asking “Which model is best?”, ask:
What capability is hardest and most expensive for us to build incorrectly?
If the answer is regulatory/claims expertise, anchor the organization around a specialist and outsource execution around it.
If the answer is growth execution, a broad agency can make sense while you build internal expertise.
If you already have substantial volume, strong marketing leadership, and enough budget to hire specialists, in-house can make increasingly strong economic sense, particularly because you retain the learning from every experiment.
One important current wrinkle: FDA's LDT framework has also made labeling/promotional-material compliance especially relevant for some laboratory-developed tests; FDA states that promotional material can constitute labeling and expects compliance with labeling requirements for most IVDs offered as LDTs by May 6, 2026. So your first step should be mapping exactly what regulatory category each kit falls into and what claims you are authorized to make, before comparing marketing vendors.
If you give me your annual revenue, approximate monthly marketing spend, number/type of diagnostic kits, and current marketing headcount, I can turn this into a quantitative agency vs. compliance partner vs. in-house decision model with suggested weights and break-even economics.
